Detalles de la búsqueda
1.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126318
2.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
3.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
4.
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study.
Mycopathologia
; 188(6): 983-994, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566212
5.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388854
6.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
7.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533127
8.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923264
9.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol
; 16(1): 32, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005697
10.
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.
Lancet Infect Dis
; 23(6): 751-761, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37254300
11.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents
; 62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478
12.
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Int J Infect Dis
; 137: 98-110, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863310
13.
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Front Oncol
; 12: 992137, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36276116
14.
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
Cancers (Basel)
; 14(22)2022 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428621
15.
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
Hemasphere
; 6(11): e789, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310756
Resultados
1 -
15
de 15
1
Próxima >
>>